SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Tuesday reported a loss of $5.4 million in its third quarter.
The San Diego-based company said it had a loss of 26 cents per share.
The biopharmaceutical company posted revenue of $18,000 in the period.
In the final minutes of trading on Tuesday, the company's shares hit 65 cents. A year ago, they were trading at $1.50.